Thermo Fisher Scientific Oncomine Dx Target Test Gets Expanded Regulatory Approval in Japan

Jun

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

Jul

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.

Jul

Featured Webinar

Cell-free DNA Testing for Fetal Aneuploidy: Lessons Learned and Implications for Clinical Practice

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.

Menu

Thermo Fisher Scientific Oncomine Dx Target Test Gets Expanded Regulatory Approval in Japan

To read the full story....

Breaking News

Potential of Blood-Based Alzheimer's Disease Biomarkers Demonstrated in New Study

SpeeDx, GSK Sign Test Supply, Development Deal

Liquid Biopsy Assay From MSKCC Approved by New York State

Federal Appeals Court Upholds Ruling Invalidating Enzo Biochem Patent

Cascade Testing for Dilated Cardiomyopathy Likely to Be Cost Effective, Analysis Finds

In Brief This Week: Bio-Techne, Molecular Testing Labs

Featured White Papers

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

Cell-free DNA Testing for Fetal Aneuploidy: Lessons Learned and Implications for Clinical Practice

What's Popular?

Liquid Biopsy Assay From MSKCC Approved by New York State

SpeeDx, GSK Sign Test Supply, Development Deal

Illumina Wins NIPT Infringement Suit Against Roche's Ariosa Diagnostics

Liquid Biopsy Monitoring, Surveillance Efforts Accelerate Across Cancer Types and Technologies

At ASM Microbe, Stakeholders Discuss Reimbursement Issues for Multiplex Infectious Disease Tests

Sponsorships